
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Avalyn Pharma (NASDAQ:AVLN) through any online brokerage.
Other companies in Avalyn Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Avalyn Pharma has a consensus price target of $62.00.
The stock price for Avalyn Pharma (NASDAQ: AVLN) is $25.76 last updated October 9, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Avalyn Pharma.
Avalyn Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for Avalyn Pharma.
Avalyn Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating...